2
Jul
We are pleased to invite you to our upcoming webinar featuring the latest advancements in ClickSeq technology, a click-chemistry-driven platform for RNA and now DNA
MORE →
24
Jun
Novartis has announced its acquisition of Regulus Therapeutics in a transaction valued at up to $1.7 billion. This strategic move aims to advance farabursen, an
MORE →
6
Jun
Development of innovative platform enhances mRNA therapeutics with improved stability, targeting and delivery Neuried, Germany (June 06, 2025) baseclick GmbH, a leader in nucleic acid
MORE →
20
May
baseclick GmbH and ClickSeq Technologies are excited to announce the launch of our DNA-ClickSeq Library Prep Kit. This new product expands our portfolio of innovative
MORE →
30
Apr
Neuried, Germany (April 30, 2025) baseclick GmbH, a leading innovator in nucleic acid-based drug and therapeutic development, and ZAGENO, one of the world’s largest marketplaces
MORE →You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information